Researchers examined surveillance data for nine U.S. states from the Emerging Infections Program, 2005 to 2014. They classified MRSA cases as hospital-onset, healthcare-associated community onset or community-associated.
The study shows that from 2005 to 2014, invasive hospital-onset and healthcare-associated community onset MRSA rates decreased, but community-associated MRSA rates did not. When examining racial disparity, the researchers found African Americans had higher rates for all three types of MRSA as compared to white people.
When the researchers limited the analysis to chronic dialysis patients, the higher healthcare-associated community onset MRSA rates among the African American population was reduced but not eliminated, despite the fact that invasive MRSA rates among all dialysis patients decreased during the same time period.
More articles on healthcare quality:
Where are the 5-star VA hospitals?
VA hospital star rankings: 1-star hospitals drop from 14 to 9 in 2018
EEOC sues Saint Thomas Health over mandatory flu shot policy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
